Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Aitken, Samuel L ^a,b   Joseph, Tiby B ^b   Shah, Dhara N ^a,b   Lasco, Todd M ^b   Palmer, Hannah R ^b   DuPont, Herbert L ^a,b,c,d   Xie, Yang ^e   Garey, Kevin W ^a,b,c  

^a UNIVERSITY OF HOUSTON   (United States)

^b Baylor Medical Center   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PROSPECTIVE STUDY; RECURRENT DISEASE; UNITED STATES; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ECONOMICS; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; UNIVERSITY HOSPITAL; UTILIZATION; VERY ELDERLY;

ANTIINFECTIVE AGENT; METRONIDAZOLE; VANCOMYCIN;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; METRONIDAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TEXAS; VANCOMYCIN;

EID: 84904788668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102848     Document Type: Article

References (13)

1. Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940.
2. Lucado J, Gould C, Elixhauser A (2012) Clostridium difficile Infections (CDI) in Hospital Stays, 2009. HCUP Statistical Brief #124. Rockville, MD: Agency for Healthcare Research and Quality.
3. Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, et al. (2012) Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 55 Suppl 2: S77-87.
4. Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, et al. (2012) Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol 33: 1031-1038.
5. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ (2008) Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 46: 497-504. (Pubitemid 351263485)
6. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455.
7. Barbut F, Kajzer C, Planas N, Petit JC (1993) Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 31: 963-967. (Pubitemid 23086545)
8. Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, et al. (2013) Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect 85: 28-32.
9. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45: 302-307. (Pubitemid 47101025)
10. Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, et al. (2014) Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol 35: 628-645.
11. Friedman B, Basu J (2004) The rate and cost of hospital readmissions for preventable conditions. Med Care Res Rev 61: 225-240. (Pubitemid 38650029)
12. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 74: 309-318.
13. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, et al. (1999) Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 20: 43-50.